register  quick_nav_bullet contact us  quick_nav_bullet about CBI  quick_nav_bullet 1.800.817.8601  quick_nav_bullet
CBI Logo  
Conferences Webinars Sponsorship Marketing Opportunities Other Services Purchase CD-ROM About CBI
  About CBI
  Company Profile
  News & Press Releases
  Registration FAQs
  Press Pass FAQs
  Accreditation
  Careers
  Speaking Opportunities
  Elite Speaker Faculty
  Directions
  Contact Us

In the News

The Center for Business Intelligence announces Domestic Outsourcing for Drug Discovery Conference

Woburn, MA - December 2, 2004 - The Center for Business Intelligence announces Domestic Outsourcing for Drug Discovery Conference, co-sponsored by The Wall Street Journal.

The Center for Business Intelligence (CBI) will hold Domestic Outsourcing for Drug Discovery on January 27-28, 2005 at Marriott San Diego in San Diego, CA. While in the past pharmaceutical and biotech companies have been hesitant to send the drug discovery process out of house, the escalating costs of drug development, the complexity of discovery research and an increasing pressure to speed up the rate of new product launches have led to an increasing trend towards outsourcing drug discovery. The conference focuses on the discovery outsourcing options that are available both through vendors, whose business model is purely contract work, and via partnering and licensing options. Industry perspectives on "Why They Outsource" are provided by Arena Pharmaceuticals, Chiron, Genentech, Novartis Pharmaceutical Corp, Purdue Pharma L.P. and Targacept, Inc. Join colleagues at this conference in learning about the many benefits an outsourcing provider or partner can offer.

  • Access to the latest technology without an ongoing commitment to the full costs and risks or an internal, up-front investment
  • Highly effective genomics and proteomics technology to enhance the ability to find more and better targets
  • Discovery chemistry technologies, including combi-chem, compu-chem, purification and characterization, to enable thorough lead generation
  • Early evaluation of drug metabolism profile and drug interaction potential
  • Combined rapid design and synthesis of focused libraries to increase the speed of development of hits to leads and subsequent medicinal chemistry optimization
  • Gram quantities of lead compounds for smaller companies with little or no synthesis capabilities
Executive Sponsors are: Ricerca Biosciences, Naeja, Discovery Partners with outstanding support provide by: Pharma IT, American Pharmaceutical Outsourcing, PharmSource, CanBiotech and Bio/Pharmaceutical Outsourcing Report. CBI events provide real life case examples given by leading experts and are excellent environments for networking. We look forward to seeing you on January 27-28, 2005 in San Diego, CA.

For more information on this event or to register, contact CBI Registration at 800-817-8601 Fax 781-939-2490 Email cbireg@cbinet.com.

or vist the conference homepage

 
Testimonials
“This conference was informative and encouraging, affording the opportunity to learn and collaborate across companies. We are all truthfully in this together!”
– Heather Resence, Supervisor Product Quality, Wyeth

“Excellent; Actionable nuggets to take back and implement”
– Kay Rayner Curling, Director, Work Life Solutions, SRA International

 
 
 
 
 
home | contact us | about CBI | privacy policy
© 2008 The Center for Business Intelligence